U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06883409) titled 'Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer' on Jan. 23.
Brief Summary: This is a study that aims to demonstrate the non-inferiority of minimally invasive surgery versus open surgery, as an approach for patients with advanced ovarian cancer who received neoadjuvant chemotherapy, giving them the benefits of laparoscopic surgery. This way they can continue with their complementary treatment.
Study Start Date: May 19, 2022
Study Type: INTERVENTIONAL
Condition:
Ovarian Neoplasms
Intervention:
PROCEDURE: Interval Cytoreduction Surgery
The procedure started with the cytoreduction of highest complexity (de...